BRNS
Price
$0.82
Change
-$0.00 (-0.00%)
Updated
Apr 24, 02:07 PM (EDT)
Capitalization
30.47M
14 days until earnings call
IMVT
Price
$14.72
Change
+$0.27 (+1.87%)
Updated
Apr 24, 02:32 PM (EDT)
Capitalization
2.45B
34 days until earnings call
Ad is loading...

BRNS vs IMVT

Header iconBRNS vs IMVT Comparison
Open Charts BRNS vs IMVTBanner chart's image
Barinthus Biotherapeutics
Price$0.82
Change-$0.00 (-0.00%)
Volume$621
Capitalization30.47M
Immunovant
Price$14.72
Change+$0.27 (+1.87%)
Volume$200
Capitalization2.45B
BRNS vs IMVT Comparison Chart
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. IMVT commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a StrongBuy and IMVT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BRNS: $0.82 vs. IMVT: $14.45)
Brand notoriety: BRNS and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 161% vs. IMVT: 69%
Market capitalization -- BRNS: $30.47M vs. IMVT: $2.45B
BRNS [@Biotechnology] is valued at $30.47M. IMVT’s [@Biotechnology] market capitalization is $2.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, BRNS is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 5 TA indicator(s) are bullish while IMVT’s TA Score has 6 bullish TA indicator(s).

  • BRNS’s TA Score: 5 bullish, 5 bearish.
  • IMVT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than BRNS.

Price Growth

BRNS (@Biotechnology) experienced а +15.73% price change this week, while IMVT (@Biotechnology) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

IMVT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.45B) has a higher market cap than BRNS($30.5M). BRNS YTD gains are higher at: -32.459 vs. IMVT (-41.663). BRNS has higher annual earnings (EBITDA): -52.89M vs. IMVT (-404.87M). IMVT has more cash in the bank: 375M vs. BRNS (106M). IMVT has less debt than BRNS: IMVT (23K) vs BRNS (12.7M). BRNS has higher revenues than IMVT: BRNS (15M) vs IMVT (0).
BRNSIMVTBRNS / IMVT
Capitalization30.5M2.45B1%
EBITDA-52.89M-404.87M13%
Gain YTD-32.459-41.66378%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash106M375M28%
Total Debt12.7M23K55,217%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSIMVT
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WWR0.520.02
+3.78%
Westwater Resources
SLDB3.550.12
+3.50%
Solid Biosciences
GTES17.380.44
+2.60%
Gates Industrial Corp
KVUE22.94-0.25
-1.08%
Kenvue
IHS4.72-0.07
-1.46%
IHS Holding Limited

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
+8.02%
SLNO - BRNS
56%
Loosely correlated
+1.22%
NGNE - BRNS
51%
Loosely correlated
+11.79%
NEUP - BRNS
50%
Loosely correlated
+1.19%
IMVT - BRNS
48%
Loosely correlated
+1.40%
TARA - BRNS
35%
Loosely correlated
+6.09%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+1.40%
ROIV - IMVT
58%
Loosely correlated
+2.98%
BRNS - IMVT
48%
Loosely correlated
+8.02%
KYMR - IMVT
45%
Loosely correlated
+6.56%
DNTH - IMVT
44%
Loosely correlated
-1.42%
RCKT - IMVT
43%
Loosely correlated
+2.44%
More